Universidad brasileña pide autorización para probar otra vacuna sinembargo.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sinembargo.mx Daily Mail and Mail on Sunday newspapers.
The impact of the Workers Party’s herd immunity policy was starkly exposed by an explosion at an oxygen cylinder fulfillment plant in Ceará last Saturday.
Scientists support the Brazilian drug regulator s decision to block the import of the Russian COVID vaccine Sputnik V due to seeing it carried a live version of a common cold-causing virus.
Top virologist Angela Rasmussen said that it raises concerns on the integrity of the manufacturing processes, according to a CBS News report.
Rasmussen added that it could be a safety issue for people with weaker immune systems if it were widespread.
Brazil s health authority announced earlier this week that it would not recommend importing the Russian COVID vaccine despite the urgent need for vaccines in the country.
All five of Anvisa s directors voted against the importing of the vaccine, according to The New York Times report.
Gobernadores brasileños no se rinden ante veto a la Sputnik V sputniknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sputniknews.com Daily Mail and Mail on Sunday newspapers.
Anvisa s board convened Monday as mandated by Supreme Federal Court (STF) Justice Ricardo Lewandowski, who had given the agency 30 days to rule on the matter
Brazil s National Health Surveillance Agency (Anvisa) Monday recommended against the import of the Russian-made Sputnik V vaccine to fight the covid-19 pandemic, citing lack of proper documents required for approval as well as other health risks the antidote may imply.
Anvisa s board convened Monday as mandated by Supreme Federal Court (STF) Justice Ricardo Lewandowski, who had given the agency 30 days to rule on the matter and denied subsequent requests to extend the deadline.
A group of Anvisa experts travelled to Russia on April 16 to collect more information about the immunizer and arrived back last Saturday. Until then, Anvisa had informed that there was a lack of technical information on the safety and efficacy of the immunizer.